KIROMIC
Live / Registered — Registered (as of 15 Apr 2025)
What this means for you
Registered since 15 Apr 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97484081
- Registration number
- 7762767
- Mark type
- Design + words
- Filed
- 30 Jun 2022
- Published for opposition
- 29 Nov 2022
- Registered
- 15 Apr 2025
- Attorney of record
- Karen Won
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical, biologic, and biopharmaceutical preparations for use in oncology, immunology, and immuno-oncology; Biopharmaceutical preparations, cell therapies, and gene therapies for preventing, managing, and treating diseases and disorders in oncology, immunology, and immuno-oncology; Biopharmaceutical preparations in the nature of T-cell allogenic therapies; Biological compounds in the nature of human cells used for enhanced delivery of therapeutic agents to targeted cells within the human body; Biological components, namely, engineered and edited human cells, being a component in therapeutic preparations for use in diseases and disorders of oncology, immunology, and immune-oncology; Therapeutic preparations in the nature of cell therapies for enhancing the targeting, delivery, and effectiveness of cancer treatments; Therapeutic agents for destroying tumor cells and inhibiting tumor growth; Human cells for medical and therapeutic use; T-cells for medical and therapeutic use
Owner
- Kiromic Biopharma, Inc., Houston, TX, US
- Kiromic Biopharma, Inc., Houston, TX, US
- Kiromic Biopharma, Inc., Houston, TX, US
Prosecution history
- 15 Apr 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 15 Apr 2025 — REGISTERED-PRINCIPAL REGISTER
- 21 Mar 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 21 Mar 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 12 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Mar 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 07 Jan 2025 — USE AMENDMENT FILED
- 12 Mar 2025 — SOU EXTENSION 4 GRANTED
- 07 Jan 2025 — SOU EXTENSION 4 FILED
- 12 Mar 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 07 Jan 2025 — TEAS STATEMENT OF USE RECEIVED
- 07 Jan 2025 — SOU TEAS EXTENSION RECEIVED
- 18 Jul 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Jul 2024 — SOU EXTENSION 3 GRANTED
- 18 Jul 2024 — SOU EXTENSION 3 FILED